Novel multifunctional antibody approved for the treatment of breast cancer

Domenico Mavilio; Lorenzo Galluzzi; Enrico Lugli

doi:10.4161/onci.24567

Novel multifunctional antibody approved for the treatment of breast cancer

Domenico Mavilio
, Lorenzo Galluzzi
, Enrico Lugli

Cancer Signaling and Microenvironment (CSM)

IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
Université Paris Cité
Centre de Recherche des Cordeliers
Université Paris-Sud

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English
Article number	e24567
Pages (from-to)	e24567
Journal	Oncoimmunology
Volume	2
Issue number	3
DOIs	https://doi.org/10.4161/onci.24567
State	Published - Mar 1 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Breast carcinoma
Cancer immunotherapy
Monoclonal antibodies
T-DM1
Trastuzumab

Access to Document

10.4161/onci.24567

Cite this

@article{71c11fecae3842789357fddacdee9800,

title = "Novel multifunctional antibody approved for the treatment of breast cancer",

keywords = "Breast carcinoma, Cancer immunotherapy, Monoclonal antibodies, T-DM1, Trastuzumab",

author = "Domenico Mavilio and Lorenzo Galluzzi and Enrico Lugli",

year = "2013",

month = mar,

day = "1",

doi = "10.4161/onci.24567",

language = "English",

volume = "2",

pages = "e24567",

journal = "Oncoimmunology",

issn = "2162-4011",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - Novel multifunctional antibody approved for the treatment of breast cancer

AU - Mavilio, Domenico

AU - Galluzzi, Lorenzo

AU - Lugli, Enrico

PY - 2013/3/1

Y1 - 2013/3/1

KW - Breast carcinoma

KW - Cancer immunotherapy

KW - Monoclonal antibodies

KW - T-DM1

KW - Trastuzumab

UR - https://www.scopus.com/pages/publications/84885351276

U2 - 10.4161/onci.24567

DO - 10.4161/onci.24567

M3 - Article

C2 - 23802090

AN - SCOPUS:84885351276

SN - 2162-4011

VL - 2

SP - e24567

JO - Oncoimmunology

JF - Oncoimmunology

IS - 3

M1 - e24567

ER -

Novel multifunctional antibody approved for the treatment of breast cancer

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this